This is further supported by the observation that mice with bone marrow-restricted disruption of cbl-associated protein (CAP), a downstream component of insulin action in control of glucose transport, are protected from obesity-associated inflammation and insulin resistance [18]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.